Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs

Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs have?

Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs has 76 citations in the OpenAlex counts ScholarIQ stores.

When was Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs published?

Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs has 2020 year in the ScholarIQ index.

What is the open-access status of Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs?

Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs has closed oa status in the ScholarIQ index.

What is the DOI of Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs?

The DOI for Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs is on the source record.

What is the PMID of Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs?

The PMID for Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs is on the source record.

What is the OpenAlex record for Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs?

The OpenAlex for Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs is on the source record.